Breakthrough chikungunya single-dose vaccine success in Phase III trials
Phase III trials for the VLA1553 vaccine against chikungunya virus indicated promising results by inducing…
Browsing: Chikungunya
Funding received for first Phase III trial of a chikungunya vaccine: June’s industry headlines
Take a look at this month’s industry headlines including an FDA approval for Zebraxa, new…
WHO reports chikungunya outbreak in Italy
As of September 14th, fourteen confirmed cases of chikungunya have been reported in Italy, specifically in Rome and the coastal area of the Lazio Region.